Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44380 clinical trials with a EudraCT protocol, of which 7392 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,380)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,380 result(s) found. Displaying page 199 of 2,219.

EudraCT Number: 2010-024013-31

Sponsor Protocol Number: CBPS804A2202

Start Date*: 2011-06-30

Sponsor Name:Novartis Pharma Services AG

Full Title: An open-label, intra-patient dose-escalation study to evaluate the safety and tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of multiple infusions of BPS804 in adults wit...

Medical condition: Hypophosphatasia (HPP) is a rare genetic metabolic disorder which results in impaired skeletal mineralization, and which is caused by the absence of or by deficient enzymatic activity of the tissue...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10010331 - Congenital, familial and genetic disorders	10049933	Hypophosphatasia	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2009-012057-38

Sponsor Protocol Number: CQTI571A2301

Start Date*: 2009-08-13

Sponsor Name:Novartis Pharma Services AG

Full Title: A 24-week randomized placebo-controlled, double-blind multi-center clinical trial evaluating the efficacy and safety of oral QTI571 as an add-on therapy in the treatment of severe pulmonary arteria...

Medical condition: Pulmonary arterial hypertension (PAH) patients who have a PVR ≥800 dynes.sec.cm-5 despite treatment with two or more specific PAH therapies

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10064911	Pulmonary arterial hypertension	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) AT (Completed) ES (Completed) FR (Completed) SE (Completed) BE (Completed) IT (Completed) NL (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2009-012076-26

Sponsor Protocol Number: 20080560

Start Date*: 2009-10-01

Sponsor Name:Amgen Inc

Full Title: A Double-blind, Placebo-controlled Study to Evaluate New or Worsening Lens Opacifications in Subjects with Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss due to Androgen-Deprivati...

Medical condition: Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy (ADT) for Non-metastatic Prostate Cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10065687	Bone loss	LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: FR (Completed) CZ (Completed) PL (Completed) LV (Completed) GR (Completed) SK (Completed) BG (Completed) HU (Completed) SI (Completed)

Trial results: View results

EudraCT Number: 2005-005087-93	Sponsor Protocol Number:	Start Date*: 2006-11-17
Sponsor Name:East Kent Hospitals NHS Trust
Full Title: A randomized double blind placebo controlled trial of Memantine in the treatment of Agitation in Alzheimers Dementia
Medical condition: Alzheimers dementia
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)

EudraCT Number: 2009-013780-19	Sponsor Protocol Number: CRAD001AES07	Start Date*: 2010-02-18
Sponsor Name:NOVARTIS FARMACÉUTICA S.A
Full Title: Estudio multicéntrico, aleatorizado, abierto, de 24 meses de duración, con dos grupos paralelos, para comparar la eficacia de everolimus en la mejora del perfil cardiovascular en el régimen con AMF...
Medical condition: Demostrar que el tratamiento inmunosupresor con everolimus (Certican®) tiene un impacto positivo en la enfermedad cardiovascular, una de las principales causas de morbilidad y mortalidad en los pac...
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results

EudraCT Number: 2009-013792-22

Sponsor Protocol Number: LEO 29102-C21

Start Date*: Information not available in EudraCT

Sponsor Name:LEO Pharma A/S

Full Title: A Phase 2, proof of concept and dose finding study, investigating treatment efficacy of LEO 29102 cream (2.5 mg/g, 1.0 mg/g, 0.3 mg/g, 0.1 mg/g, 0.03 mg/g), LEO 29102 cream vehicle, and Elidel (Pim...

Medical condition: Diagnosis of atopic dermatitis graded as mild to moderate according to the Rajka and Langeland system.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10003639	Atopic dermatitis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed) FI (Completed)

Trial results: View results

EudraCT Number: 2011-000213-39

Sponsor Protocol Number: 102210

Start Date*: 2011-06-27

Sponsor Name:Erasmus MC

Full Title: Intramuscular corticosteroid injections in hip osteoarthritis: a double-blinded randomized controlled trial

Medical condition: Hip osteoarthritis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10018407	Glucocorticoids normal	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-016203-32

Sponsor Protocol Number: 20090340

Start Date*: 2009-11-19

Sponsor Name:Amgen Inc

Full Title: An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects with immune (Idiopathic) Thrombocytopenia Purpura (ITP).------------...

Medical condition: Thrombocytopenia in pediatric subjects with ITP---------Sujetos Pediátricos Trombocitopénicos con Púrpura Trombocitopénica Inmune (Idiopática) (PTI)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.0		10043558	Thrombocytopenia purpura	LLT

Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: ES (Completed) Outside EU/EEA

Trial results: View results

EudraCT Number: 2009-016827-72	Sponsor Protocol Number: GAL-Moa-003	Start Date*: 2010-01-12
Sponsor Name:Galenica AB
Full Title: A multicentre, randomized, double-blind, safety and efficacy non-inferiority, intra-individual study, comparing Mometasone furoate Galenica 0.1% cream with Elocon 0.1% cream and placebo in patients...
Medical condition: Mild to moderate plaque psoriasis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results

EudraCT Number: 2010-022066-28

Sponsor Protocol Number: CFTY720DDE01

Start Date*: 2011-01-18

Sponsor Name:Novartis Pharma GmbH

Full Title: A 6-month multicenter, single-arm, open-label study to investigate changes in biomarkers after initiation of treatment with 0.5 mg fingolimod (FTY720) in patients with relapsing-remitting multiple ...

Medical condition: relapsing remitting Multiple Sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	10029205 - Nervous system disorders	10028245	Multiple sclerosis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2008-006889-29	Sponsor Protocol Number: MEC-2008-322	Start Date*: 2009-02-25
Sponsor Name:ErasmusMC
Full Title: A pilotstudy comparing systemic versus locoregional injection of radiolabelled somatostatin analogues in patients with neuroendocrine Gastro-Entero_Pancreatic (GEP) tumors.
Medical condition: Uptake of Octreoscan in sst-2 receptor positive Gastro Entero Pancreatic neuroendocrine tumors injected in systemical and locoregional way.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-020941-29

Sponsor Protocol Number: AC-061A201

Start Date*: 2010-11-03

Sponsor Name:Actelion Pharmaceuticals Ltd

Full Title: A multi-center, double-blind, randomized, active reference, parallel group study to evaluate the efficacy, safety and tolerability of a 10-day twice daily oral administration of 3 doses of ACT-1798...

Medical condition: Clostridium difficile infection

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10054236	Clostridium difficile infection	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: SE (Prematurely Ended) DE (Prematurely Ended) GB (Prematurely Ended) IT (Prematurely Ended)

Trial results: View results

EudraCT Number: 2008-001440-39

Sponsor Protocol Number: FC/hulp001

Start Date*: 2008-05-12

Sponsor Name:Asociación de Investigación Hepatológica y Transplante Hepático Infantil

Full Title: Estudio clinico intrapaciente de biodisponibilidad relativa de dos formulaciones de tacrolimus: Prograf (comprimidos de liberación normal) y Advagraf (comprimidos de liberación sostenida) en adoles...

Medical condition: Pacientes con transplante hepático de 12 a 18 años de edad, en situación clínica estable y con niveles estables de Tacrolimus.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10024716	Liver transplantation	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2008-001457-18

Sponsor Protocol Number: 6108K2-2000-ES

Start Date*: 2008-12-15

Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc.

Full Title: Single-blind, Randomized, Phase 1/2 Trial of the Safety, Tolerability, and Immunogenicity of Meningococcal Group B rLP2086 Vaccine in Healthy Infants

Medical condition: Healthy infant vaccination against Meningitis B

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10027202	Meningitis bacterial	LLT

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: ES (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-005853-47

Sponsor Protocol Number: 2007-190

Start Date*: 2008-02-12

Sponsor Name:Medicinsk afdeling

Full Title: Evaluering af røde morfindråber til behandling af dyspnø hos lungecancerpatienter

Medical condition: Patienter med lungecancer i terminalstadiet

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10025063	Lung cancer stage unspecified (excl metastatic tumours to lung)	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2007-005862-10

Sponsor Protocol Number: AGO/2007/011

Start Date*: 2009-05-29

Sponsor Name:University Hospital Ghent

Full Title: Randomized, double-blind study for the evaluation of the effect of losartan versus placebo on aortic root dilatation in patients with Marfan syndrome under treatment with beta-blockers.

Medical condition: Marfan syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10026829	Marfan's syndrome	LLT

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: (No results available)

EudraCT Number: 2007-005865-37	Sponsor Protocol Number: PIL-629-WEB-0128-I	Start Date*: Information not available in EudraCT
Sponsor Name:Medizinische Fakultät der Technischen Universität München, Vertreten durch den Dekan
Full Title: Levofloxacin vs Piperacillin/Sulbactam and Sultamicillin in patients with acute cholecystitis. A double blind, randomized study.
Medical condition: acute cholecystitis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: DE (Prematurely Ended)
Trial results: View results

EudraCT Number: 2009-010116-15	Sponsor Protocol Number: CTU 052 D	Start Date*: 2010-05-31
Sponsor Name:RIEMSER Arzneimittel AG
Full Title: A multicentre double blind placebo controlled clinical dose- finding study for three doses of Antiadipositum X 112 T® (Cathine-hydrochloride) vs. placebo in 240 patients with a body mass index (BMI...
Medical condition: diet-related obesity diagnosed by BMI of 30 to 40 kg/m² or diet-related obesity diagnosed by BMI of 27 to 40 kg/m² in patient with coexisting risk factors like hyperlipidaemia, type 2 diabetes mell...
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2009-010172-21

Sponsor Protocol Number: ENJOIH01

Start Date*: 2009-08-27

Sponsor Name:Elena Santagostino

Full Title: An Investigator-sponsored study on rFVIIa prophylaxis in children with haemophilia A and inhibitors Estudio promovido por el investigador sobre profilaxis con rFVIIa en niños con hemofilia A e inh...

Medical condition: Hemofilia A

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10056492	Haemophilia A with anti factor VIII	LLT

Population Age: Newborns, Infants and toddlers, Children, Under 18

Gender: Male

Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) FR (Ongoing) PL (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2010-022821-14

Sponsor Protocol Number: 2010-022821-14

Start Date*: 2010-11-11

Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA

Full Title: Cardiovascular Outcomes of Replacement with Testosterone. Role of testosterone replacement therapy in patients with heart failure.

Medical condition: MALE HYPOGONADISM

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10014698		SOC
	9.1		10007541		SOC

Population Age: Adults, Elderly

Gender: Male

Trial protocol: IT (Ongoing)

Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue Feb 10 07:52:30 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA